BioPharma Credit Share Forecast, Price & News

Wall Street analysts have given BioPharma Credit a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BioPharma Credit wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

BioPharma Credit's stock was trading at GBX 0.98 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BPCR stock has decreased by 2.0% and is now trading at GBX 0.96.
View which stocks have been most impacted by COVID-19.

BioPharma Credit announced a dividend on Wednesday, May 26th. Investors of record on Thursday, June 3rd will be given a dividend of GBX 0.02 per share on Wednesday, June 30th. This represents a yield of 1.8%. The ex-dividend date of this dividend is Thursday, June 3rd. The official announcement can be seen at this link.
View BioPharma Credit's dividend history.

BioPharma Credit pays an annual dividend of GBX 0.07 per share and currently has a dividend yield of 7.22%. BPCR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of BioPharma Credit is 107.69%. Payout ratios above 75% are not desirable because they may not be sustainable.
View BioPharma Credit's dividend history.

Some companies that are related to BioPharma Credit include Allied Minds (ALM), Wilmington Capital Management (WCM.A), Sherborne Investors (Guernsey) B (SIGB), Ventus VCT D (VEND), Emmerson (EML), Canadian Life Companies Split (LFE), Golden Prospect Precious Metals (GPM), Lighthouse Group (LGT), ScotGems (SGEM), BlackRock Income and Growth Investment Trust (BRIG), Orbit Garant Drilling (OGD), Aberdeen International (AAB), Founders Advantage Capital Corp. (FCF.V) (FCF), First Property Group (FPO) and Digital 9 Infrastructure (DGI9).
View all of BPCR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other BioPharma Credit investors own include (AFPO.L) (AFPO), Altius Minerals (ATUSF), LiDCO Group Plc (LID.L) (LID), 21512 (SAT.L) (SAT), San Juan Basin Royalty Trust (SJT), ANGLE (AGL), Hochschild Mining (HOC), SPX FLOW (FLOW), Fulcrum Utility Services (FCRM) and DX (Group) (DX).

BioPharma Credit trades on the London Stock Exchange (LON) under the ticker symbol "BPCR."

Shares of BPCR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of BPCR stock can currently be purchased for approximately GBX 0.96.

BioPharma Credit has a market capitalization of £13.24 million and generates £110.02 million in revenue each year.

The official website for BioPharma Credit is www.bpcruk.com.

BioPharma Credit is headquartered at Beaufort HSE, 51 New North Road, EXETER, EX4 4EP, United Kingdom.

BioPharma Credit's mailing address is Beaufort HSE, 51 New North Road, EXETER, EX4 4EP, United Kingdom. The company can be reached via phone at 44 13 9247 7500.